SCHEMBL8621606

SCHEMBL8621606

Cc1nc(C(C)C2CCN(C(=O)OCc3ccccc3)CC2)sc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
CYP2C19 P33261 1/20 0.52
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.46
IDH1 O75874 1/20 0.46
GRIN2B Q13224 10/20 0.46
HTT P42858 1/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2C9 P11712 4/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP3A4 P08684 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8594128 0.82 SMN1; SMN2 (0.55) SMN1; SMN2CYP2C19NPC1RAB9AL3MBTL1
SCHEMBL8621479 0.80 SMN1; SMN2 (0.48) SMN1; SMN2CYP2C19NPC1RAB9AIDH1
SCHEMBL8621609 0.79 SMN1; SMN2 (0.51) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL14514898 0.78 SMN1; SMN2 (0.68) SMN1; SMN2CYP2C19NPC1RAB9AIDH1
SCHEMBL10369008 0.77 SMN1; SMN2 (0.64) SMN1; SMN2CYP2C19NPC1RAB9AL3MBTL1
SCHEMBL15140950 0.77 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL3933949 0.77 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL387622 0.77 SMN1; SMN2 (0.67) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B
SCHEMBL8549063 0.76 TSHR (0.53) SMN1; SMN2CYP2C19NPC1RAB9AL3MBTL1
SCHEMBL11990212 0.76 SMN1; SMN2 (0.65) SMN1; SMN2CYP2C19NPC1RAB9AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817677-A ANTITHROMBOSIS AGENTS DR. KARL THOMAE GMBH (DE) 1998-10-06 US disclosed